Philips Prevails in Shareholder Recall Dispute
A Dutch court rejected shareholders' demands for an investigation into allegations of misleading disclosures and management failures related to the recall of approximately 15 million sleep apnea devices in 2021. The court found no evidence that the company was aware of the issues prior to the warning and confirmed that early intervention by its officials was not required. Despite ongoing investigations in other countries and a settlement of $1.1 billion in the United States, the court upheld the company's decision and dismissed the charges against it.
Size: 120%Text Size
Notice: This Is an AI-Generated Summary
Comments (0)